| Literature DB >> 34908618 |
Gehad G Mohamed1, M M Omar1, Yasmin M Ahmed1.
Abstract
Mononuclear chelates of Cr(III), Mn(II), Fe(III), Ni(II), Cu(II), Zn(II) and Cd(II) resulted from new tridentate Schiff base ligand, 4-((1-(5-acetyl-2,4-dihydroxyphenyl)ethylidene)amino)-1,5-dimethyl-2-phenyl-1H-pyrazol-3(2H)-one, were synthesized. Metal to ligand ratio was found to be1 : 1, which was revealed via elemental analysis and characterized via various spectroscopic tools. IR has point out that the coordination of the ligand towards the metal ions was carried out via NOO donor atoms. UV-Vis, 1H NMR spectral data, molar conductivity measurements, BET surface area, melting points and theoretically through density function theory were used such as characterizing techniques in supporting further interpretation of the complexes structures. The complexes were octahedral except Cu(II) and Ni(II) complexes were tetrahedral as suggested from the magnetic moment measurement. The complexes were found to have surface area, pore volume and particle radius of 23-176 m2 g-1, 0.02-0.33 cc/g and 8.71-4.32 nm, respectively, as pointed out from BET measurement. Schiff base ligand and metal complexes were tested in vitro to estimate their antimicrobial activity opposed to Gram-negative and Gram-positive bacterial and fungal organisms. MOE 2008 was used headed for screen potential drugs with molecular docking by the protein sites of new coronavirus and the study was constructed to molecular docking without validation through MD simulations.Entities:
Keywords: Metal complexes; Microbial and anticancer activity; Schiff base ligand; density functional theory; molecular docking of COVID-19; spectroscopic analyses
Year: 2021 PMID: 34908618 PMCID: PMC8662136 DOI: 10.1002/zaac.202100245
Source DB: PubMed Journal: Z Anorg Allg Chem ISSN: 0044-2313 Impact factor: 1.414
Analytical and physical data of Schiff base ligand (H2L) and its metal complexes.
|
Compound (Molecular Formula) |
Colour (%yield) |
M.p. (°C) |
% Found (Calcd.) |
Λm Ω−1mol−1 cm2 |
μeff (BM) | |||
|---|---|---|---|---|---|---|---|---|
|
C |
H |
N |
M | |||||
|
H2L |
orange (92) |
190 |
66.39 (66.42) |
5.49 (5.53) |
11.01 (11.07) |
– |
|
– |
|
[Cr(H2L)(H2O)2Cl]Cl2 ⋅ 2H2O |
yellow (85) |
>300 |
41.28 (41.34) |
4.64 (4.76) |
6.72 (6.89) |
8.41 (8.53) |
113 |
3.99 |
|
[Mn(H2L)(H2O)2Cl]Cl ⋅ 2H2O |
brown (84) |
206 |
43.18 (43.66) |
4.99 (5.02) |
7.20 (7.27) |
9.39 (9.52) |
63 |
5.41 |
|
[Fe(H2L)(H2O)2Cl]Cl2 |
brown (83) |
>300 |
43.37 (43.61) |
4.29 (4.33) |
7.19 (7.27) |
9.56 (9.69) |
103 |
5.28 |
|
[Ni(H2L)(H2O)]Cl2 ⋅ 4H2O |
green (80) |
>300 |
42.01 (42.06) |
5.07 (5.17) |
7.00 (7.01) |
9.71 (9.85) |
107 |
4.39 |
|
[Cu(H2L)Cl]Cl ⋅ 2H2O |
Greenish blue (86) |
>300 |
45.73 (45.82) |
4.43 (4.55) |
7.22 (7.64) |
11.18 (11.55) |
74 |
2.8 |
|
[Zn(H2L)(H2O)Cl2] ⋅ 2H2O |
Dark brown (84) |
169 |
43.83 (44.23) |
4.63 (4.74) |
7.30 (7.37) |
11.37 (11.41) |
24 |
Diamagnetic |
|
[Cd(H2L)(H2O)Cl2] |
brown (85) |
158 |
43.25 (43.39) |
3.78 (3.96) |
7.21 (7.23) |
19.19 (19.35) |
9 |
Diamagnetic |
Figure 1Structures of Schiff base metal complexes.
IR spectra of H2L ligand and its metal complexes.
|
Assignment |
ν(OH) phenolic and H2O |
ν(C=N) azomethine |
ν(C=O) resorcinol |
ν(C=O) antipyrine |
ρr(H2O) and ρw(H2O). |
ν(M−O) |
ν(M−N) |
|---|---|---|---|---|---|---|---|
|
H2L |
– |
1589m |
1652br |
– |
– |
– | |
|
[Cr(H2L)(H2O)2Cl]Cl2 ⋅ 2H2O |
3424br,3148br |
1531sh |
1643 m |
1620s |
757, 698 |
575 |
452 |
|
[Mn(H2L)(H2O)2Cl]Cl ⋅ 2H2O |
3428br,3192br |
1560s |
1636br |
839, 666 |
578 |
421 | |
|
[Fe(H2L)(H2O)2Cl]Cl2 |
3417br,3165br |
1539m |
1648sh |
1595s |
840, 692 |
546 |
453 |
|
[Ni(H2L)(H2O)]Cl2 ⋅ 4H2O |
3429br |
1550s |
1626br |
876, 720 |
591 |
443 | |
|
[Cu(H2L)Cl]Cl ⋅ 2H2O |
3425br,3244br |
1541sh |
1630sh |
1601s |
836, 694 |
599 |
429 |
|
[Zn(H2L)(H2O)Cl2] ⋅ 2H2O |
3439br,3264br |
1579s |
1651sh |
1620s |
840, 699 |
579 |
459 |
|
[Cd(H2L)(H2O)Cl2] |
3421br |
1587m |
1652sh |
1630s |
889, 696 |
590 |
448 |
Figure 21H NMR spectra of (a) H2L, (b) Zn(II) and (c) Cd(II) complexes.
Figure 3The optimized structures of (A) H2L and (B) Cd(II) complex.
Figure 4Molecular electrostatic potential map of (A) H2Land (B)[Cd(H2L)(H2O)Cl2]complex. The electron density isosurface is 0.004 a.u.
The different optimized and quantum chemical parameters of H2L and its Cd(II) complex.
|
Bond lengths (Å) |
H2L |
[Cd(H2L)(H2O)Cl2] |
|---|---|---|
|
C(1)−N(2) |
1.46 |
1.47 |
|
C(1)−O(24) |
1.25 |
1.33 |
|
N(2)−N(3) |
1.41 |
1.43 |
|
N(2)−C(4) |
1.47 |
1.47 |
|
N(3)−C(15) |
1.47 |
1.47 |
|
N(3)−C(19) |
1.50 |
1.49 |
|
C(25)−N(26) |
1.46 |
1.50 |
|
N(26)−C(27) |
1.31 |
1.31 |
|
C(29)−O(40) |
1.43 |
1.45 |
|
C(34)−O(42) |
1.43 |
1.43 |
|
O(40)−H(41) |
0.96 |
0.96 |
|
O(42)−H(43) |
0.96 |
0.96 |
|
C(44)−O(45) |
1.26 |
1.26 |
|
Cd(50)−Cl(51) |
— |
2.40 |
|
Cd(50)−Cl(52) |
— |
2.40 |
|
Cd(50)−O(53) |
— |
3.11 |
|
O(40)−Cd(50) |
— |
3.06 |
|
N(26)−Cd(50) |
— |
3.06 |
|
O(24)−Cd(50) |
— |
3.08 |
Main calculated optical transition with composite ion in terms of molecular orbitals.
|
Compound |
Transition |
Excitation energy (ev) |
λmax Calc. (nm) |
λmax exp. (nm) |
Oscillating strength |
|---|---|---|---|---|---|
|
H2L |
HOMO LUMO |
3.39 |
366 |
395 |
0.147 |
|
[Cd(H2L)Cl2(H2O)] |
HOMO LUMO |
3.42 |
363 |
340 |
0.142 |
Figure 5a) Theoretical electronic absorption transitions for H2L in ethanol solvent. b) Theoretical electronic absorption transitions for Cd(II) complex in DMF solvent.
Thermoanalytical results (TG and DTG) of Schiff base ligand (H2L) and its metal complexes.
|
Complex |
TG range (°C) |
DTGmax (°C) |
n* |
Mass loss Total mass loss Estim (Calcd) % |
Assignment |
Residues |
|---|---|---|---|---|---|---|
|
H2L |
30–330 330–900 |
195, 255 400 |
2 1 |
37.69 (37.25) 60.17 (62.75) 97.69 (100.00) |
‐ Loss of C10H21. ‐ Loss of C11N3O4. |
|
|
[Cr(H2L)(H2O)2 Cl]Cl2 ⋅ 2H2O |
30–120 120–900 |
66 218, 700, 810 |
1 3 |
5.64 (5.90) 69,70 (71.31) 75.34 (77.21) |
‐ Loss of 2H2O. ‐ Loss of 1.5Cl2, 2H2O and C16H22N3O2.5. |
1/2Cr2O3+5C |
|
[Mn(H2L)(H2O)2Cl]Cl ⋅ 2H2O |
30–375 375–900 |
71, 125, 155 379, 812 |
3 2 |
34.50 (34.81) 41.62 (42.43) 76.12 (77.24) |
‐ Loss of Cl2,4H2O, C4H10. ‐ Loss of C12H11N3O3. |
MnO+5C |
|
[Fe(H2L)(H2O)2Cl]Cl2 |
30–900 |
139, 204 |
2 |
78.15 (77.78) 78.15 (77.78) |
‐ Loss of 1.5Cl2, 2H2O and C17H21N3O2.5. |
1/2Fe2O3+4C |
|
[Ni(H2L)(H2O)]Cl2 ⋅ 4H2O |
30–250 250–900 |
73, 157 183, 424 |
2 2 |
27.29 (26.87) 50.91 (50.74) 78.2 (77.61) |
‐ Loss of 5H2O, Cl2. ‐ Loss of C16H21N3O3. |
NiO+5C |
|
[Cu(H2L)Cl]Cl ⋅ 2H2O |
30–135 135–900 |
68 169, 270, 550 |
1 3 |
6.56 (6.55) 69.02 (70.19) 75.58 (76.74) |
‐ Loss of 2H2O. ‐ Loss of Cl2, C17H21N3O3. |
CuO+4C |
|
[Zn(H2L)(H2O)Cl2] ⋅ 2H2O |
30–180 180–365 365–900 |
61, 155 178, 285 464, 800 |
2 2 2 |
9.47 (9.48) 19.77 (20.89) 43.44 (42.67) 72.68 (73.02) |
‐ Loss of 3H2O. ‐ Loss of Cl2, 3CH4 ‐ Loss of C12H9N3O3 |
ZnO+6C |
|
[Cd(H2L)(H2O)Cl2] |
30–160 160–245 245–480 480–900 |
132 217 268 561, 833 |
1 1 1 2 |
3.65 (3.10) 11.83 (12.22) 24.70 (24.45) 33.30 (32.03) 73.48 (71.80) |
‐ Loss of H2O. ‐ Loss of Cl2. ‐ Loss of C10H 21. ‐ Loss of C7N3O3. |
CdO+4C |
* n=number of decomposition steps.
Figure 6Mass spectra of (A) H2L ligand and (B) [Cd(H2L)(H2O)Cl2]complex.
BET surface area and band gaps of metal chelates.
|
Samples |
SBET (m2/g) |
Pore volume (cc/g) |
Average Particle radius (nm) |
BET surface area (m2 g−1) |
Band gap energy (eV) |
Average Pore Size (nm) |
|---|---|---|---|---|---|---|
|
[Cr(H2L)(H2O)2Cl]Cl2 ⋅ 2H2O |
119 |
0.20 |
7.75 |
176 |
3.41 |
2.28 |
|
[Mn(H2L)(H2O)2Cl]Cl ⋅ 2H2O |
90 |
0.15 |
4.32 |
118 |
3.41 |
2.57 |
|
[Fe(H2L)(H2O)2Cl]Cl2 |
13 |
0.02 |
5.83 |
23 |
3.68 |
1.95 |
|
[Ni(H2L)(H2O)]Cl2 ⋅ 4H2O |
51 |
0.09 |
5.32 |
95 |
3.14 |
2.02 |
|
[Cu(H2L)Cl]Cl ⋅ 2H2O |
79 |
0.14 |
8.71 |
156 |
3.44 |
1.73 |
|
[Zn(H2L)(H2O)Cl2] ⋅ 2H2O |
200 |
0.33 |
6.10 |
83 |
3.69 |
7.85 |
|
[Cd(H2L)(H2O)Cl2] |
77 |
0.13 |
7.96 |
63 |
3.66 |
4.08 |
Biological activity of Schiff base ligand (H2L) and its metal complexes.
|
Sample |
Inhibition zone diameter (mm/mg sample) | ||||
|---|---|---|---|---|---|
|
|
Bacterial species |
Fungal species | |||
|
|
G+ |
G− |
|
| |
|
|
|
|
|
| |
|
Control: DMSO |
0.0 |
0.0 |
0.0 |
0.0 | |
|
Standard |
Amikacin Antibacterial agent |
10 |
6 |
– |
– |
|
|
ketokonazole Antifungal agent |
– |
– |
8 |
9 |
|
H2L |
12 |
14 |
0 |
10 | |
|
[Cr(H2L)(H2O)2Cl]Cl2⋅2H2O |
9 |
9 |
0 |
0 | |
|
[Mn(H2L)(H2O)2Cl]Cl⋅2H2O |
10 |
11 |
0 |
0 | |
|
[Fe(H2L)(H2O)2Cl]Cl2. |
11 |
13 |
14 |
12 | |
|
[Ni(H2L)(H2O)]Cl2⋅4H2O |
16 |
15 |
0 |
19 | |
|
[Cu(H2L)Cl]Cl⋅2H2O |
14 |
14 |
0 |
0 | |
|
[Zn(H2L)(H2O)Cl2]⋅2H2O |
14 |
14 |
0 |
10 | |
|
[Cd(H2L)(H2O)Cl2] |
20 |
24 |
11 |
20 | |
Figure 7Biological activity of Schiff base ligand (H2L) and its metal complexes.
Figure 8Activity index of Schiff base ligand (H2L) and its metal complexes against (A) different fungal (B) different Gram (+ve) and Gram (−ve) bacteria.
Anticancer effects of Schiff base ligand and its metal complexes in terms of % Cell Inhibition at 100 μg/ml concentration.
|
Samples |
% Cell Inhibition |
Surviving fraction (MCF7) |
IC 50 (μg/ml) | ||||
|---|---|---|---|---|---|---|---|
|
0.0 |
5.0 |
12.5 |
25 |
50 | |||
|
H2L |
64 |
|
|
|
|
|
– |
|
[Cr(H2L)(H2O)2Cl]Cl2 ⋅ 2H2O |
64 |
|
|
|
|
|
– |
|
[Mn(H2L)(H2O)2Cl]Cl ⋅ 2H2O |
72 |
1 |
0.85 |
0.73 |
0.51 |
0.33 |
26 |
|
[Fe(H2L)(H2O)2Cl]Cl2 |
75 |
1 |
0.88 |
0.71 |
0.64 |
0.25 |
33 |
|
[Ni(H2L)(H2O)]Cl2 ⋅ 4H2O |
75 |
1 |
0.88 |
0.81 |
0.62 |
0.3 |
34 |
|
[Cu(H2L)Cl]Cl ⋅ 2H2O |
70 |
1 |
1 |
0.73 |
0.33 |
0.31 |
19.6 |
|
[Zn(H2L)(H2O)Cl2] ⋅ 2H2O |
67 |
|
|
|
|
|
– |
|
[Cd(H2L)(H2O)Cl2] |
64 |
|
|
|
|
|
– |
Figure 9Anticancer effects of Schiff base ligand and its metal complexes in terms of % cell inhibition at 100 μg/ml concentration.
Figure 102D Molecular docking simulation studies of hydrophobic interactions of the Schiff base ligand (A) H2L and (B) Cr(III), (C) Mn(II), (D) Fe(III), (E) Ni(II), (F) Cu(II), (G) Zn(II) and (H) Cd(II) complexes with amino acid residues of PDB ID: 6XBHare shown with dotteFigure S11. 3D Molecular docking simulation studies of the interaction between (A) Schiff base ligand H2L and (B) Cr(III), (C) Mn(II), (D) Fe(III), (E) Ni(II), (F) Cu(II), (G) Zn(II) and (H) Cd(II) complexes with the active site of the receptor of PDB ID: 6XBH. The docked conformation of the compound is shown in ball and stick representation
Energy values obtained in docking calculations of H2L and its metal complexes with to Crystal structure of the SARS‐CoV‐2 (COVID‐19) main protease in complex with inhibitor UAW247 (6XBH).
|
Compound |
moiety |
Receptor site |
Interaction |
Distance (Aο) |
E (kcal/mol) |
|---|---|---|---|---|---|
|
Ligand (H2L) |
O 16 |
OE2 GLU 166 |
H‐donor |
2.88 |
−2.5 |
|
C2 26 |
SD MET 165 |
H‐donor |
3.45 |
−1.1 | |
|
5‐ring |
NE2 GLN 189 |
pi‐H |
3.36 |
−0.9 | |
|
[Cr(H2L)(H2O)2Cl]Cl2 ⋅ 2H2O |
O15 |
O THR 24 |
H‐donor |
3.09 |
−1.0 |
|
O54 |
SD MET 49 |
H‐donor |
3.38 |
−28.6 | |
|
6‐ring |
CG2 THR 25 |
pi‐H |
4.55 |
−0.7 | |
|
[Mn(H2L)(H2O)2Cl]Cl ⋅ 2H2O |
O 22 |
SD MET 165 |
H‐donor |
4.03 |
−0.4 |
|
CL45 49 |
SD MET 49 |
H‐donor |
3.47 |
−3.1 | |
|
O46 50 |
SD MET 49 |
H‐donor |
3.07 |
−0.9 | |
|
O 54 |
OG1 THR 25 |
H‐donor |
2.70 |
−1.4 | |
|
CL45 49 |
NE2 GLN 189 |
H‐acceptor |
3.77 |
−3.3 | |
|
5‐ring |
CG2 THR 25 |
pi‐H |
3.92 |
−0.7 | |
|
6‐ring |
5‐ring HIS 41 |
pi‐pi |
3.64 |
−0.0 | |
|
[Fe(H2L)(H2O)2Cl]Cl2. |
O 15 |
O GLU 166 |
H‐donor |
2.86 |
−5.0 |
|
O 54 |
OD1 ASN 142 |
H‐donor |
2.91 |
−3.6 | |
|
[Ni(H2L)(H2O)]Cl2 ⋅ 4H2O |
O 50 |
SD MET 49 |
H‐donor |
3.31 |
−4.9 |
|
[Cu(H2L)Cl]Cl ⋅ 2H2O |
O 15 |
O ASP 187 |
H‐donor |
2.88 |
−2.9 |
|
CL 50 |
CG GLN 189 |
H‐acceptor |
3.34 |
−0.8 | |
|
CL 50 |
NE2 GLN 189 |
H‐acceptor |
3.08 |
−3.0 | |
|
[Zn(H2L)(H2O)Cl2] ⋅ 2H2O |
CL45 49 |
CA ASN 142 |
H‐acceptor |
4.24 |
−0.6 |
|
CL46 50 |
CA ASN 142 |
H‐acceptor |
4.03 |
−0.9 | |
|
CL46 50 |
N GLY 143 |
H‐acceptor |
3.06 |
−8.0 | |
|
CL46 50 |
N CYS 145 |
H‐acceptor |
4.27 |
−1.9 | |
|
CL46 50 |
SG CYS 145 |
H‐acceptor |
3.60 |
−0.9 | |
|
6‐ring |
N GLU 166 |
pi‐H |
4.80 |
−0.7 | |
|
[Cd(H2L)(H2O)Cl2] |
O 15 |
SD MET 165 |
H‐donor |
3.51 |
−2.6 |
|
CL45 49 |
SG CYS 145 |
H‐donor |
3.92 |
−3.8 | |
|
CL45 49 |
CA MET 165 |
H‐acceptor |
3.48 |
−2.2 | |
|
CL45 49 |
N GLU 166 |
H‐acceptor |
4.16 |
−1.1 | |
|
CL46 50 |
N GLU 166 |
H‐acceptor |
3.34 |
−6.5 | |
|
CL46 50 |
CB GLU 166 |
H‐acceptor |
3.64 |
−0.8 |
Scheme 1Preparation of the Schiff base ligand and metal complexes.